Mining the Hippo signalling pathway for novel anti-cancer therapeutics

   Faculty of Health, Science, Social Care and Education

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
  Dr Hachemi Kadri  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Candidates are invited to join the Kadri Lab where our research focuses on developing innovative chemical approaches for the discovery of novel therapeutics to address unmet global health needs. Research is multidisciplinary spanning the fields of chemical biology, medicinal chemistry, computer-aided drug design, high throughput screening, protein crystallography, and biochemistry. This project will build on our recent exciting findings in deciphering the important role of the Hippo signalling pathway and its implications in various health diseases particularly cancer. The aim is to capitalise on the group’s expertise in the use of the powerful PROteolysis TArgeting Chimera (PROTAC) technology to develop novel small molecule modulators of this pathway.

The candidate will have access to state-of-the-art laboratories, facilities, and equipment available at Kingston University London. This multidisciplinary drug discovery project will provide an excellent opportunity to receive high-quality training in a range of techniques at the interface of chemistry and biology including computer-assisted drug design, chemical synthesis, targeted protein degradation, cell culture and biochemical based techniques for biological evaluation of the synthesised compounds.

Funding Notes

there is no funding for this project
Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.

PhD saved successfully
View saved PhDs